- Home
- NLOP vs HRTX Comparison
NLOP vs HRTX Comparison
Compare NLOP & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NLOP | HRTX |
|---|---|---|
| Founded | N/A | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.2M | 228.3M |
| IPO Year | 2022 | 2007 |
Fundamental Metrics
Financial Performance| Metric | NLOP | HRTX |
|---|---|---|
| Price | $11.27 | $0.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 149.0K | ★ 2.5M |
| Earning Date | 05-19-2026 | 05-11-2026 |
| Dividend Yield | ★ 52.20% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | $118,915,000.00 | ★ $154,904,000.00 |
| Revenue This Year | N/A | $15.28 |
| Revenue Next Year | N/A | $20.29 |
| P/E Ratio | $6.80 | ★ N/A |
| Revenue Growth | N/A | ★ 7.36 |
| 52 Week Low | $11.24 | $0.74 |
| 52 Week High | $34.53 | $2.30 |
Technical Indicators
Market Signals| Indicator | NLOP | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 30.46 | 36.33 |
| Support Level | $11.24 | $0.74 |
| Resistance Level | $13.50 | $0.87 |
| Average True Range (ATR) | 0.41 | 0.08 |
| MACD | -0.13 | -0.05 |
| Stochastic Oscillator | 2.58 | 4.74 |
Price Performance
Historical ComparisonAbout NLOP Net Lease Office Properties of Beneficial Interest
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns, operates, and finances a diversified portfolio of office properties mainly leased to corporate tenants on a single-tenant, net-lease basis. The company operates as a single operating and reportable segment focused on owning and managing office properties that generate revenue mainly from long-term lease agreements with tenants.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.